Teva statement on european commission decision; company to appeal

Tel aviv, israel, oct. 31, 2024 (globe newswire) -- teva pharmaceuticals industries ltd. (nyse: and tase: teva) is responding to the european decision following its investigation into the company's practices regarding copaxone® -- the standard-of-care treatment for multiple sclerosis – and announcing its intention to appeal the judgement and fine imposed.
TEVA Ratings Summary
TEVA Quant Ranking